focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShaftesbury Capital Regulatory News (SHC)

Share Price Information for Shaftesbury Capital (SHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.142%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 141.00
SHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New medium-term bank loan of £300 million

5 Dec 2023 07:30

RNS Number : 7000V
Shaftesbury Capital PLC
05 December 2023

5 December 2023

Shaftesbury Capital PLC

New medium-term bank loan of £300 million

Shaftesbury Capital PLC (the "Company") is pleased to announce that it has signed a £300 million unsecured loan agreement (the "Facility") with an initial maturity of three years, with the option to extend the tenor by a further two periods of one year each, subject to lender approval.

The proceeds of the Facility, combined with the existing cash resources of the Company, will be used to repay the remaining balance (£376 million) of the unsecured loan, which was arranged at the time of the merger and drawn in April 2023 to fund the repayment of the Shaftesbury PLC secured bonds. The unsecured loan is due to mature in 2024. As announced in the trading update on 27 November 2023, cash balances at 30 September 2023, adjusted for recent asset sales, were approximately £200 million and the Covent Garden revolving credit facility of £300 million is undrawn.

The Facility comprises term loan and revolving credit elements, which will provide the Company with the flexibility to manage the level of drawn debt, liquidity and finance costs. The Facility includes a £125 million uncommitted accordion feature which may allow the Company to increase the total revolving facility commitments.

As a result of the refinancing, the weighted average maturity of the Company's drawn debt will be extended to over 5 years. The current weighted average cost of debt is unchanged at 4.2 per cent, which reduces (taking into account interest income on cash deposits and the benefit of interest rate hedging) to an effective cash cost of 3.3 per cent.

The Facility has been provided by Santander UK PLC, HSBC UK Bank PLC and BNP Paribas, London Branch. The Company was advised on the Facility by Rothschild & Co and Herbert Smith Freehills.

Situl Jobanputra, Chief Financial Officer of Shaftesbury Capital, commented, "We are pleased to have completed the early refinancing of the £576 million loan through this facility and other initiatives this year, which highlight the attractiveness of our exceptional portfolio and further enhance our capital structure."

-ENDS-

Enquiries

Shaftesbury Capital PLC: ?+44 (0)20 3214 9150

Situl Jobanputra Chief Financial Officer

Sarah Corbett ?Director of Commercial Finance and Investor Relations

Graham Keer ?Group Treasurer

About Shaftesbury Capital

Shaftesbury Capital PLC ("Shaftesbury Capital") is the leading central London mixed-use REIT and is a constituent of the FTSE-250 Index. Our property portfolio, valued at £4.9 billion as at June 2023, extends to 2.9 million square feet of lettable space across the most vibrant areas of London's West End. With a diverse mix of restaurants, cafés, bars, shops, residential and offices, our destinations include the high footfall, thriving neighbourhoods of Covent Garden, Carnaby, Soho and Chinatown, together with holdings in Fitzrovia. Our properties are close to the main West End Underground stations and transport hubs for the Elizabeth Line. Shaftesbury Capital shares are listed on the London Stock Exchange and the Johannesburg Stock Exchange.

www.shaftesburycapital.com

Our purpose

Our purpose is investing to create thriving destinations in London's West End where people enjoy visiting, working and living.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDTABFTMTAMMLJ
12
Date   Source Headline
16th Apr 202411:30 amRNSAdditional Listing
16th Apr 20249:30 amRNS2023 Final Dividend - Exchange Rate
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202410:45 amRNSHolding(s) in Company
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
18th Mar 202411:15 amRNSBlock listing Interim Review
14th Mar 20241:45 pmRNSPublication of 2023 Annual Report and AGM notice
11th Mar 20247:00 amRNSAcquisition of 25-31 James Street, Covent Garden
6th Mar 20247:00 amRNSPost-offer Intention Statements
5th Mar 20242:35 pmRNSNotice to Bondholders
5th Mar 20242:30 pmRNSHolding(s) in Company
1st Mar 202412:30 pmRNSHolding(s) in Company
29th Feb 20242:30 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSFinal Results
7th Feb 202411:30 amRNSNotification of new external directorship
30th Jan 202410:00 amRNSNotice of Results
12th Jan 20241:45 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:30 amRNSNew medium-term bank loan of £300 million
28th Nov 20231:00 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSInvestor event and trading update
21st Nov 202310:30 amRNSNotification of new external directorship
21st Nov 202310:20 amRNSHolding(s) in Company
20th Nov 202311:20 amRNSHolding(s) in Company
17th Nov 20232:30 pmRNSHolding(s) in Company
15th Nov 20231:30 pmRNSHolding(s) in Company
14th Nov 20231:30 pmRNSDirector/PDMR Shareholding
6th Nov 20239:50 amRNSHolding(s) in Company
1st Nov 20238:55 amRNSHolding(s) in Company
30th Oct 20233:30 pmRNSHolding(s) in Company
12th Oct 20233:20 pmRNSHolding(s) in Company
25th Sep 202311:30 amRNSHolding(s) in Company
19th Sep 20231:00 pmRNSHolding(s) in Company
18th Sep 20234:15 pmRNSNotice to Bondholders
18th Sep 202310:00 amRNSBlock listing Interim Review
13th Sep 20231:15 pmRNSHolding(s) in Company
7th Sep 20231:00 pmRNSHolding(s) in Company
15th Aug 20239:00 amRNS2023 Interim Dividend - Exchange Rate
14th Aug 20237:00 amRNSNew long-term loan facility of £200 million
8th Aug 202310:15 amRNSNotice to Bondholders
3rd Aug 20237:00 amRNSHalf-year Report
15th Jun 20233:45 pmRNSResult of AGM
14th Jun 20237:00 amRNSTrading Update
28th Apr 20239:50 amRNSBlock listing Interim Review
18th Apr 202312:45 pmRNSBonds Redemption and Utilisation of Loan Facility
31st Mar 20239:00 amRNSTotal Voting Rights
28th Mar 20234:00 pmRNSNotice of AGM and Scrip Dividend Scheme
24th Mar 20233:40 pmRNSDirector/PDMR Shareholding
24th Mar 20233:00 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.